Lombard Odier Asset Management (Europe)’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.79M | Sell |
34,053
-45
| -0.1% | -$11.6K | 0.62% | 58 |
|
|
2025
Q1 | $7.63M | Sell |
34,098
-12,500
| -27% | -$2.8M | 0.61% | 59 |
|
|
2024
Q4 | $10.7M | Sell |
46,598
-22,574
| -33% | -$5.16M | 0.69% | 40 |
|
|
2024
Q3 | $16.9M | Sell |
69,172
-30,631
| -31% | -$7.48M | 0.72% | 32 |
|
|
2024
Q2 | $19.1M | Buy |
99,803
+46,816
| +88% | +$8.96M | 0.9% | 22 |
|
|
2024
Q1 | $10.5M | Buy |
+52,987
| New | +$10.5M | 0.63% | 50 |
|
|
2023
Q2 | – | Sell |
-2,700
| Closed | -$591K | – | 284 |
|
|
2023
Q1 | $591K | Hold |
2,700
| – | – | 0.03% | 241 |
|
|
2022
Q4 | $562K | Sell |
2,700
-300
| -10% | -$62.4K | 0.02% | 250 |
|
|
2022
Q3 | $655K | Hold |
3,000
| – | – | 0.03% | 234 |
|
|
2022
Q2 | $629K | Buy |
+3,000
| New | +$629K | 0.03% | 237 |
|
|
2021
Q2 | – | Sell |
-1,230
| Closed | -$239K | – | 219 |
|
|
2021
Q1 | $239K | Buy |
+1,230
| New | +$239K | 0.01% | 219 |
|
|
2020
Q4 | – | Sell |
-1,248
| Closed | -$214K | – | 348 |
|
|
2020
Q3 | $214K | Buy |
+1,248
| New | +$214K | 0.01% | 322 |
|
|
2020
Q1 | – | Sell |
-1,791
| Closed | -$278K | – | 376 |
|
|
2019
Q4 | $278K | Hold |
1,791
| – | – | 0.02% | 304 |
|
|
2019
Q3 | $242K | Hold |
1,791
| – | – | 0.02% | 325 |
|
|
2019
Q2 | $219K | Buy |
+1,791
| New | +$219K | 0.02% | 357 |
|
|
2019
Q1 | – | Sell |
-1,791
| Closed | -$204K | – | 378 |
|
|
2018
Q4 | $204K | Buy |
+1,791
| New | +$204K | 0.02% | 319 |
|